The Units Problem: How Reconstitution, Storage, and Syringe Math Quietly Decide Your Microdose
Two people can be prescribed the same 0.25 mg microdose and end up receiving meaningfully different amounts of drug. Nobody made a dramatic mistake. The gap opened up in the vial, the fridge, and the barrel of the syringe.
20%
DOSE SWING FROM A SINGLE MISREAD UNIT WHEN YOUR MICRODOSE IS ONLY 5 UNITS WIDE
7 u
TYPICAL VOLUME LOST TO HUB DEAD SPACE ON A STANDARD LUER LOCK SYRINGE
28–56
DAYS MOST COMPOUNDED MULTI DOSE VIALS ARE DATED FOR ONCE RECONSTITUTED AND REFRIGERATED
Most conversations about GLP-1 microdosing stop at the number. Zero point two five milligrams. A quarter of a starter dose. It sounds settled, the way a prescription is supposed to sound.
Then you look at what has to happen between that number and your skin. A lyophilized powder has to be dissolved in a specific volume of liquid. The resulting concentration has to be converted into marks on a syringe barrel that was designed for insulin, not for peptides. The vial has to survive weeks in a refrigerator that opens forty times a day. At the end of that chain, some amount of drug enters your body, and it is not automatically the amount on the label.
This is not an argument against microdosing. It is an argument for understanding the parts of the protocol that are usually treated as clerical. At full titration doses, a small handling loss disappears into the noise. At a quarter dose, the same loss is a quarter of your protocol.
The diluent volume is a dosing decision
A compounding pharmacy receives a vial holding, say, 5 mg of semaglutide as a dry cake. Nothing about that vial specifies a concentration yet. Concentration is created at the moment someone chooses how much bacteriostatic water to add. Put in 1 mL and you have a 5 mg per mL solution. Put in 5 mL and you have 1 mg per mL. The drug is identical. What changed is how much liquid your dose is spread across.
That choice determines everything downstream, because a U-100 insulin syringe is marked in units where one unit equals one hundredth of a millilitre. A 0.25 mg dose from the concentrated vial is 5 units. The same dose from the dilute vial is 25 units. Five marks versus twenty five marks, for the exact same amount of medication.
Same 0.25 mg dose, five different syringe readings
Units drawn on a U-100 insulin syringe for a 0.25 mg microdose, by how much diluent was added to a 5 mg vial.
Arithmetic only. Your pharmacy sets the concentration and your prescriber sets the dose. Always draw against the label you were given.
Why five units is a hard place to live
Syringe barrels do not get more precise when your dose gets smaller. The smallest readable increment stays a single unit whether you are drawing five of them or fifty. What changes is what one unit is worth as a fraction of your dose. Miss by one mark at 5 units and you have taken 20 percent more or less than intended. Miss by one mark at 25 units and the error is 4 percent.
This is the quiet reason many low dose protocols land on a more dilute preparation than a titrating patient would use. It is not about gentleness. It is about giving the eye something to aim at. A dose that occupies a visible stretch of the barrel is a dose you can repeat next week.
"The smaller the dose, the wider it should sit on the barrel. Precision is not a property of the drug. It is a property of how far you spread it."
What one misread mark costs you
Percentage dose error from a single unit misread, plotted against how many units the dose occupies. Pure arithmetic, not a measurement study.
Reading a concentration off a label
Every compounded vial arrives with a concentration printed on it, usually as milligrams per millilitre, alongside a beyond use date. Those two numbers plus your prescribed dose are enough to know exactly what your syringe should read. The table below shows how the common preparations translate. It exists so you can sanity check what you are holding, not so you can build your own.
| Vial | Diluent | Concentration | 0.25 mg reads | 0.5 mg reads | Readability |
|---|---|---|---|---|---|
| 5 mg | 1 mL | 5.0 mg/mL | 5 u | 10 u | Too tight |
| 5 mg | 2 mL | 2.5 mg/mL | 10 u | 20 u | Workable |
| 5 mg | 3 mL | 1.7 mg/mL | 15 u | 30 u | Good |
| 10 mg | 2 mL | 5.0 mg/mL | 5 u | 10 u | Too tight |
| 10 mg | 4 mL | 2.5 mg/mL | 10 u | 20 u | Workable |
| 10 mg | 5 mL | 2.0 mg/mL | 12.5 u | 25 u | Good |
Units shown assume a U-100 insulin syringe where 100 units equals 1 mL. Never reconstitute or re dilute a vial yourself.
The fridge is doing more work than you think
A dry peptide cake is stable for a long time. The moment it goes into solution, a clock starts. Peptides in water slowly degrade through hydrolysis and through gradual unfolding, and both processes speed up with heat. This is why the beyond use date on a reconstituted vial is measured in weeks rather than the years printed on the unopened one.
The failure mode is rarely dramatic. Nobody boils their vial. What actually happens is a countertop weekend, a car ride in July, a hotel room where the mini fridge was never turned on. Each of those bites a piece out of the potency you will be relying on six weeks from now, and nothing about the liquid looks different afterward. You find out through a plateau you cannot explain.
Potency retention by storage temperature
Illustrative degradation curves for a reconstituted peptide solution over eight weeks. Directional model based on general peptide stability behavior, not product specific assay data.
- 2–8°C refrigerated
- ~22°C room
- ~30°C warm
Conceptual curves for illustration. Follow the beyond use date and storage instructions on your own pharmacy label.
Cold, not frozen
Two to eight degrees Celsius is the target. Freezing a reconstituted solution is worse than a warm afternoon, because ice crystal formation and the concentration changes around them physically damage the folded structure. The back wall of a refrigerator and the freezer side of a shared shelf are the two places vials most often freeze by accident.
Dark, or at least not sunlit
Light exposure adds an oxidative pathway on top of the thermal one. Most vials arrive in a carton for exactly this reason, and the carton is not packaging you are meant to discard on day one.
Swirled, never shaken
Mixing a peptide by shaking creates an air and liquid interface that unfolds the chains at the surface. Foam is the visible evidence. Gentle rolling between the palms dissolves the cake without generating it.
The dose you leave in the needle
Push a syringe plunger all the way down and some liquid stays behind in the hub where the needle meets the barrel. On a standard luer lock syringe that trapped volume runs roughly 60 to 100 microliters, which is 6 to 10 units. For someone injecting 50 units of something, that is a rounding error absorbed by the manufacturer's overfill. For someone injecting a 10 unit microdose, it can be most of the dose.
Insulin syringes with permanently bonded needles have almost no hub to trap anything, which is the unglamorous reason they became the default tool for low dose work. The choice of syringe is not a comfort preference at this scale. It is part of the dose.
Volume stranded in the hub, in syringe units
Approximate dead space by syringe and needle configuration. Ranges vary by manufacturer.
Where handling actually goes wrong
The mistakes people make are boring, which is exactly why they persist. Almost nobody gets the concentration math catastrophically wrong. They shake the vial because it dissolves faster. They leave it out while they finish a phone call and then forget. They peel the pharmacy label off because it looks clinical on the shelf, and three weeks later they cannot remember which vial was opened when.
A dated label and a consistent shelf in the fridge solve most of it. Writing the reconstitution date directly on the vial with a marker, keeping the carton, and putting the vial in the same spot every single time removes the two failure modes that account for the bulk of lost potency.
Reported handling errors, by relative frequency
Directional pattern from provider and pharmacy reports on multi dose vial handling. Not incidence data from a controlled study.
"A vial that never left the fridge and still has its date written on it is worth more than any adjustment you could make to the protocol."
Why one vial has to last so long
Part of what draws people to microdosing is arithmetic. A 5 mg vial gives a patient on a 1.7 mg maintenance dose about three injections. The same vial gives someone on a 0.25 mg microdose twenty. That is the difference between three weeks and five months from the same purchase, and it is a large part of why low dose protocols became popular outside of any clinical argument.
But it cuts the other way too. Stretching a vial across months means the beyond use date, not the volume remaining, is usually what ends it. Many microdosers discard liquid they paid for because the calendar ran out first. That is the trade being made, and it is worth making deliberately rather than discovering it in week seven.
Doses available from a single 5 mg vial
Theoretical dose count by prescribed amount, before accounting for dead space losses or a beyond use date that arrives first.
Theoretical maximums. Real dose counts are lower once hub losses and the vial's beyond use date are applied.
The unglamorous part is the protocol
People spend months optimizing injection day, protein targets, and which peptide to add next, while the vial that carries all of it sits in a door shelf getting warm every time someone reaches for the milk. At a quarter dose there is no margin left to absorb that. The concentration on the label, the date written on the cap, the temperature it lives at, and the number of marks you can actually see on the barrel are not administrative details around the protocol. On a microdose, they are most of it.
None of this is something to solve alone. Reconstitution belongs to a licensed compounding pharmacy, the concentration belongs to your prescriber, and the beyond use date belongs to whoever mixed it. What belongs to you is smaller and still matters: read the label, keep the carton, write the date, keep it cold, and count the marks twice.
"At full dose, sloppy handling costs you a little. At a quarter dose, it costs you the experiment."
Frequently asked questions
Why does a microdose need more diluent than a standard dose?
Because precision on an insulin syringe is measured in whole units, and a unit is a unit no matter how small your dose is. Drawing 0.25 mg from a concentrated vial might mean 5 units on the barrel, where being one mark off changes the dose by 20 percent. The same 0.25 mg from a more dilute vial might be 15 or 25 units, where a one mark miss costs you 6 percent or 4 percent. Nothing about the drug changed. The readability of the measurement did.
Can I change how much diluent my pharmacy used?
No. The concentration on your label is what your prescriber calculated your dose against, and it is what your syringe markings were matched to. If the units you are being asked to draw feel unreadably small, that is a conversation to have with the prescriber, who can request a different concentration on the next fill. Adding water to a vial yourself breaks sterility and makes the label wrong for every remaining dose.
What is bacteriostatic water actually doing?
It contains roughly 0.9 percent benzyl alcohol, a preservative that suppresses bacterial growth after the stopper has been punctured more than once. Plain sterile water has no preservative, which is why anything reconstituted with it is meant for a single use. The preservative is the entire reason a multi dose vial can sit in a fridge for weeks instead of hours.
Why does shaking a vial matter so much?
Peptides are folded chains, and their activity depends on that shape holding. Vigorous shaking creates an air and liquid interface that unfolds them at the surface, which shows up as foam and sometimes as faint haze. Swirling or rolling the vial gently between your palms mixes the powder without generating that interface. Foam on top of a freshly mixed vial is a signal that some fraction of what you paid for is no longer in a usable shape.
How long does a reconstituted vial actually last?
The date on your pharmacy label is the answer that governs, and for most compounded multi dose vials it lands somewhere between 28 and 56 days refrigerated. That window assumes the vial went back to two to eight degrees Celsius after every draw. Every hour it spends warm eats into it, and repeated warm and cold cycles do more damage than a single steady stretch at either temperature.
What is syringe dead space and should I care?
Dead space is the fluid trapped in the needle hub after you push the plunger all the way down. On a standard luer lock setup it can be 60 to 100 microliters, which is 6 to 10 units. If your microdose is 10 units, you may be losing nearly half of it to the hub. Insulin syringes with permanently attached needles have almost none, which is one of the practical reasons they dominate low dose protocols.
Does it matter if I see tiny particles in the vial?
Yes, and it is not a judgment call you should try to make yourself. A properly reconstituted solution should be clear and colorless with nothing floating in it. Visible particulates, persistent cloudiness, or a color shift are all reasons to stop, photograph the vial, and contact the pharmacy that dispensed it. Injecting past that point is the kind of risk that has no upside.
Is the money saved by microdosing mostly a reconstitution effect?
Partly. A 5 mg vial split into 0.25 mg increments yields twenty doses instead of the three a titrating patient would get from the same vial, which is why the cost per week falls so sharply at the low end. That arithmetic is real, but it is also the reason accuracy matters more here than anywhere else. When one vial is stretched across five months, a mixing or storage mistake is not a wasted day. It is a wasted season.
Clinical references
- United States Pharmacopeia. General Chapter 797, Pharmaceutical Compounding, Sterile Preparations. 2023 revision.
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals, an update. Pharmaceutical Research. 2010.
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. International Journal of Pharmaceutics. 1999.
- Strickley RG, Lambert WJ. A review of formulations of commercially available antibodies and peptide therapeutics. Journal of Pharmaceutical Sciences. 2021.
- Strauss K, et al. Pandemic influenza preparedness, the critical role of the syringe. Vaccine. 2006. (Low dead space syringe volumes.)
- Trimingham S, et al. Accuracy of low dose insulin syringe measurement. Journal of Diabetes Science and Technology. 2013.
- US Food and Drug Administration. Compounding and the FDA, questions and answers on compounded GLP-1 products. 2024.
- Centers for Disease Control and Prevention. Safe practices for medical injections, single dose and multi dose vial guidance. 2024.
Medical disclaimer. This article is for general educational and informational purposes only. It is not medical advice, not compounding instructions, and not a substitute for professional guidance, diagnosis, or treatment from a qualified healthcare provider. Reconstitution of any injectable medication should be performed only by a licensed compounding pharmacy, and the concentration, dose, storage conditions, and beyond use date printed on your own pharmacy label always govern over any figure shown here. The charts on this page are illustrative arithmetic and directional models rather than product specific assay data. GLP-1 microdosing is off label and outcomes vary between individuals. Never mix, dilute, re dilute, transfer, or adjust a medication yourself, and never start, stop, or change a dose without consulting a licensed prescriber who can supervise your protocol.